Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gesellschaft für medizinische und technische Investitionen (GMTI) is a German investment holding company focused on the healthcare, medical technology, and life sciences sectors. Managed by the Schoeller family, the firm serves as a strategic investment vehicle for long-term capital placement in innovative medical solutions. GMTI is a primary shareholder in AOP Health (formerly AOP Orphan), a leading European provider of integrated therapies for rare diseases and critical care. The company leverages its deep industry expertise to support the development and commercialization of specialized pharmaceutical products and medical devices across Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gesellschaft für medizinische und technische Investitionen.